Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

2011 ASCO Annual Meeting

4 - 8 Jun 2011
Stockholm, Sweden
Early detection and prevention of melanoma (6/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Early detection and prevention of melanoma (6/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Metastatic melanoma: changes in epidemiology and current standards of care (1/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Metastatic melanoma: changes in epidemiology and current standards of care (1/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Recent advances in advanced melanoma: ipilimumab (2/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Recent advances in advanced melanoma: ipilimumab (2/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Recent advances in advanced melanoma: BRAF inhibitors (3/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Recent advances in advanced melanoma: BRAF inhibitors (3/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Combination of newer agents in advanced melanoma (4/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Combination of newer agents in advanced melanoma (4/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Guidelines and recommendations for advanced melanoma (5/6)
European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof P...
Guidelines and recommendations for advanced melanoma (5/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )
15 Aug 2011
Development of lenvatinib for thyroid cancer
Prof Steven Sherman - MD Anderson Cancer Center, Texas, USA
Development of lenvatinib  for thyroid cancer ( Prof Steven Sherman - MD Anderson Cancer Center, Texas, USA )
28 Jun 2011
Health care issues in low and middle income countries.
Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Health care issues in low and middle income countries. ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
24 Jun 2011
The changing landscape of melanoma therapies: indications of better patient outc...
Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof Reinhard...
The changing landscape of melanoma therapies: indications of better patient outcome ( Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof Reinhard Dummer )
24 Jun 2011
Role of vemurafenib in melanoma treatment
Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK
Role of vemurafenib in melanoma treatment ( Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK )
24 Jun 2011
Research from the Sarah Cannon Research Institute
Dr Howard (Skip) Burris - The Sarah Cannon Research Institute, Nashville, USA
Research from the Sarah Cannon Research Institute ( Dr Howard (Skip) Burris - The Sarah Cannon Research Institute, Nashville, USA )
24 Jun 2011
Clinical research at Sarah Cannon UK
Dr Tobias Arkenau - The Sarah Cannon Research Institute, London, UK
Clinical research at Sarah Cannon UK ( Dr Tobias Arkenau - The Sarah Cannon Research Institute, London, UK )
24 Jun 2011
2011 Gianni Bonadonna Breast Cancer Award and ASCO breast highlights
Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy
2011 Gianni Bonadonna Breast Cancer Award and ASCO breast highlights ( Prof Luca Gianni - Istituto Nazionale Tumori, Milan, Italy )
23 Jun 2011
Treatment options for ovarian cancer
Prof Martin Gore - The Royal Marsden Hospital, London, UK
Treatment options for ovarian cancer ( Prof Martin Gore - The Royal Marsden Hospital, London, UK )
23 Jun 2011
Standard of care for ovarian cancer
Prof Stan Kaye - Royal Marsden Hospital, Surrey, UK
Standard of care for ovarian cancer ( Prof Stan Kaye - Royal Marsden Hospital, Surrey, UK )
23 Jun 2011
Optimal therapy for children with high risk ALL
Dr Eric Larsen - Maine Children’s Cancer Program, Portland, USA
Optimal therapy for children with high risk ALL ( Dr Eric Larsen - Maine Children’s Cancer Program, Portland, USA )
23 Jun 2011
MD Anderson Institute of Personalised Cancer Therapy
Prof John Mendelsohn - MD Anderson Cancer Center, Texas USA
MD Anderson Institute of Personalised Cancer Therapy ( Prof John Mendelsohn - MD Anderson Cancer Center, Texas USA )
23 Jun 2011
Importance of metastases in cancer growth
Prof Larry Norton - Memorial Sloan-Kettering Cancer Center, New York, USA
Importance of metastases in cancer growth ( Prof Larry Norton - Memorial Sloan-Kettering Cancer Center, New York, USA )
23 Jun 2011
Investigating metabolism for cancer therapy
Dr Marston Linehan - National Cancer Institute, Maryland, USA
Investigating metabolism for cancer therapy ( Dr Marston Linehan - National Cancer Institute, Maryland, USA )
23 Jun 2011
Treatment options for prostate cancer
Prof Otis Brawley - American Cancer Society, Atlanta, USA
Treatment options for prostate cancer ( Prof Otis Brawley - American Cancer Society, Atlanta, USA )
23 Jun 2011
Sarah Canon Research Institute; overview and future
Dee Anna Smith – Sarah Canon Research Institute, Nashville, USA
Sarah Canon Research Institute; overview and future ( Dee Anna Smith – Sarah Canon Research Institute, Nashville, USA )
23 Jun 2011
Association of diabetes and cancer epidemiology
Dr Lorraine Lipscombe – University of Toronto, Canada
Association of diabetes and cancer epidemiology ( Dr Lorraine Lipscombe – University of Toronto, Canada )
23 Jun 2011
Ovarian cancer developments
Prof Eric Pujade-Lauraine - Hôpital Hôtel-Dieu, Paris, France
Ovarian cancer developments ( Prof Eric Pujade-Lauraine - Hôpital Hôtel-Dieu, Paris, France )
23 Jun 2011
Care of patients with advanced prostate cancer
Dr Eleni Efstathiou - MD Anderson Cancer Center, Texas USA and University of Ath...
Care of patients with advanced prostate cancer ( Dr Eleni Efstathiou - MD Anderson Cancer Center, Texas USA and University of Athens, Greece )
23 Jun 2011
New hopes for prostate cancer
Prof Cora Sternberg - San Camillo Forlanini Hospital, Rome, Italy
New hopes for prostate cancer ( Prof Cora Sternberg - San Camillo Forlanini Hospital, Rome, Italy )
23 Jun 2011
ASCO 2011: Developments in ovarian cancer therapy
Prof Christian Marth - Innsbruck Medical University, Austria
ASCO 2011: Developments in ovarian cancer therapy ( Prof Christian Marth - Innsbruck Medical University, Austria )
23 Jun 2011
UN summit on non-communicable diseases
Dr Eduardo Cazap - SLACOM, Buenos Aires, Argentina
UN summit on non-communicable diseases ( Dr Eduardo Cazap - SLACOM, Buenos Aires, Argentina )
22 Jun 2011
Links between cancer and weight, ethnic origin or social status
Dr Jennifer Ligibel - Dana-Farber Cancer Institute, Boston, USA
Links between cancer and weight, ethnic origin or social status ( Dr Jennifer Ligibel - Dana-Farber Cancer Institute, Boston, USA )
22 Jun 2011
Importance of geriatric oncology
Prof Hyman Muss - University of North Carolina Medical School, USA
Importance of geriatric oncology ( Prof Hyman Muss - University of North Carolina Medical School, USA )
22 Jun 2011
ASCO 2011: Key head and neck cancer research
Prof Jacques Bernier - Clinique de Genolier, Genolier, Switzerland
ASCO 2011: Key head and neck cancer research ( Prof Jacques Bernier - Clinique de Genolier, Genolier, Switzerland )
22 Jun 2011
New oncogene target for breast cancer: LMTK3
Prof Justin Stebbing - Imperial College London, UK
New oncogene target for breast cancer: LMTK3 ( Prof Justin Stebbing - Imperial College London, UK )
22 Jun 2011
Olaparib maintenance therapy for ovarian cancer and updates from ICON7
Prof Jonathan Ledermann - UCL Cancer Institute, London, UK
Olaparib maintenance therapy for ovarian cancer and updates from ICON7 ( Prof Jonathan Ledermann - UCL Cancer Institute, London, UK )
22 Jun 2011
The ENERGY trial
Prof Cheryl Rock - University of California, USA
The ENERGY trial ( Prof Cheryl Rock - University of California, USA )
20 Jun 2011
Advances in breast cancer research from ASCO 2011
Dr David Miles - Mount Vernon Hospital, London, UK
Advances in breast cancer research from ASCO 2011 ( Dr David Miles - Mount Vernon Hospital, London, UK )
20 Jun 2011
PTEN expression does not diminish trastuzumab effectiveness
Prof Edith Perez - Mayo Clinic, Florida, USA
PTEN expression does not diminish trastuzumab effectiveness ( Prof Edith Perez - Mayo Clinic, Florida, USA )
20 Jun 2011
Combining oral targeted therapies shows early anti-tumour activity for advanced ...
Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
20 Jun 2011
Vall d´Hebron Institute of Oncology; advancing personalized and targeted therapi...
Prof José Baselga - Massachusetts General Hospital, Boston, USA; Prof Josep Tabe...
Vall d´Hebron Institute of Oncology; advancing personalized and targeted therapies against cancer ( Prof José Baselga - Massachusetts General Hospital, Boston, USA; Prof Josep Tabernero, Vall d´Hebron Institute of Oncology, Barcelona, Spain )
17 Jun 2011
Translational research from the Vall d'Hebron Institute of Oncology
Prof Joan Seoane - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Translational research from the Vall d'Hebron Institute of Oncology ( Prof Joan Seoane - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
17 Jun 2011
Cancer prevention through education
Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy
Cancer prevention through education ( Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy )
17 Jun 2011
Highlights from 2011 and ASCO’s future
Prof George Sledge - Indiana University, USA
Highlights from 2011 and ASCO’s future ( Prof George Sledge - Indiana University, USA )
17 Jun 2011
Future for immunotherapies
Prof Angus Dalgleish - St George’s University, London, UK
Future for immunotherapies ( Prof Angus Dalgleish - St George’s University, London, UK )
17 Jun 2011
High dose chemotherapy helps combat neuroblastoma
Prof Ruth Ladenstein - University of Vienna, Austria
High dose chemotherapy helps combat neuroblastoma ( Prof Ruth Ladenstein - University of Vienna, Austria )
17 Jun 2011
Ipilimumab improves survival in metastatic melanoma
Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Ipilimumab improves survival in metastatic melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Jun 2011
Exemestane significantly reduces risk of invasive breast cancer in high-risk, po...
Dr Paul Goss - Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital...
Exemestane significantly reduces risk of invasive breast cancer in high-risk, postmenopausal women ( Dr Paul Goss - Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital, Boston, USA )
17 Jun 2011
New melanoma drug gives 63 percent reduction in risk of death compared to dacarb...
Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center
New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine ( Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center )
17 Jun 2011
Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at ...
Dr Gunnar Kristensen - Norwegian Radium Hospital, Oslo, Norway
Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence ( Dr Gunnar Kristensen - Norwegian Radium Hospital, Oslo, Norway )
17 Jun 2011
Ethics of early-phase clinical trials
Dr Steven Joffe – Dana-Farber Cancer Institute, Boston, USA
Ethics of early-phase clinical trials ( Dr Steven Joffe – Dana-Farber Cancer Institute, Boston, USA )
17 Jun 2011
ASCO 2011 highlights
Prof Gordon McVie – ecancer Managing Editor
ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )
16 Jun 2011